Halozyme Therapeutics shares owned by Davidson Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Davidson Capital Management
from 13F filings
Historical chart of Davidson Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Davidson Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Davidson Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.1M | 56k | 73.34 |
| 2025-06-30 | $2.9M | 56k | 52.02 |
| 2025-03-31 | $3.9M | 61k | 63.81 |
| 2024-12-31 | $2.7M | 57k | 47.81 |
| 2024-09-30 | $1.5M | 27k | 57.24 |
| 2024-06-30 | $9.9k | 190 | 52.36 |
| 2024-03-31 | $7.5k | 184 | 40.68 |
More positions owned by Davidson Capital Management
View all positions for Davidson Capital Management